471results about How to "Protective function" patented technology

The invention discloses a freeze beverage containing isomaltose hypgather and process for preparation, wherein the raw materials comprise the following constituents (by weight ratio): cow's milk and / or dairy product and / or dairy product analogues 0-90%, isomaltose hypgather 0. 01-10. 0%, sugar 4. 0-16. 0%, stabilizing agent 0. 1-1. 0%, sour flavor agent 0-0. 7%, edible flavoring essence 0. 01-0. 4% and balancing water.

The present invention is directed to film coating systems for use on oral dosage forms such as compressed tablets and orally-ingestible substrates which have improved pearlescent qualities. The film coating systems can be applied either directly to a substrate or after the substrate has been coated with a subcoat. In preferred aspects, the pearlescent film coating is prepared as a dry powder mixture containing a cellulosic polymer, a detackifier, a gloss enhancer, and a pearlescent pigment. Film coating compositions containing an aqueous suspension of the powder mixtures, methods of applying the coatings to substrates and the coated substrates are also disclosed.

The invention discloses zirconia aluminosilicate glass which is a high-alkali high-alumina glass composition system containing zirconia, is suitable to the manufacture of glass products with high surface hardness and good scratch-resistant property, and has the advantages of being capable of chemical strengthening treatment. The chemical composition (wt percent) of the glass is as follows: 55 to 65 of SiO2, 10 to 20 of Al2O3, 0 to 2 of Li2O, 5 to 15 of Na2O, 0 to 5 of K2O, 1 to 6 of MgO, 0.5 to 4 CaO, 1.5 to 6.0 of ZrO2, 0.35 to 1.0 of SnO2, 0.2 to 1.2 of CeO2 and 0.4 to 1.3 of Sb2O3. The glass material is suitable to screen protecting materials of flat panel display products (such as liquid crystal displays, liquid crystal display-televisions, media machines, touch screens, automated teller machines, cell phones, and personal digital assistants), and can effectively prevent the surface impact and scratch damage of the flat panel display products.

The invention discloses an aortic valve stent (100) capable of preventing perivalvular leakage. The aortic valve stent (100) capable of preventing perivalvular leakage comprises a stent (110) and an artificial valve (104), wherein the stent (110) is composed of a plurality of grid cells (112); the artificial valve (104) is connected to the grid cells (112); a sealing unit (106) is arranged at the bottom of the stent (110); the sealing unit (106) is made from a metal memory material and laminated; in a natural state, the sealing unit (106) is arched outwards along the axial direction of the stent and of an annular structure along the peripheral direction of the stent (110); one end of the sealing unit (106) is free and is a free end (116); the other end of the sealing unit (106) is fixed with the bottom of the stent (110) by a fixing element, and is a fixed end (126); when the sealing unit (106) is compressed to enter a sheathing canal, the free end (116) of the sealing unit (106) turns towards the bottom end of the stent and around the fixed end (126), thus the sealing unit (106) is not superposed with the stent (110).

The invention relates to a calibration method for clearance between rolls of hot-rolling vertical rolls, which mainly solves the technical problem that strip steel is deficient in quality because verticality and alignment to calibration of vertical rolls are not considered in current methods. The technical scheme is that the calibration method for clearance between rolls of hot-rolling vertical rolls comprises the steps of: 1, finding a rolling center line and marking; 2, additionally arranging two position marks on a transverse slipway of a hot-rolling vertical roll device, and marking the distance from the marks to the rolling center line as |ZB|; 3, hitting apertures on both sides of the vertical rolls to marked positions, wherein a roll block is inside a marking line and aligned with the marking line; 4, measuring the distance from the lower ends on both sides of the vertical rolls to the rolling center line, and marking the measuring point as a point A, the radius of the rolls as R / 2 and the distances from A to a vertical roll operating side and from A to a transmission side as |OA| and |DA|; 5, comparing the measured value |OA|+R / 2 on the operating side with |ZB|, wherein if the difference is in a precision range, the verticality is good, and if the difference is not in the precision range, the clearance between rolls on the operating side is adjusted so that the difference is in the precision control range; 6, adjusting the clearance between rolls on the transmission side by the adjusting method in the step 5; and 7, measuring the total aperture of the vertical rolls, inputting the measured values and calibrating the clearance between rolls of vertical rolls after adjusting the verticality and alignment.

The invention discloses an integrated switch cabinet intelligent operating system. The integrated switch cabinet intelligent operating system comprises eight modules which are a switch cabinet state indication module, a temperature and humidity online monitoring module, an intelligent operating module, an arc light protecting module, a protecting measuring module, a breaker online monitoring module, a communication module and a human and machine interface module. By means of the modules, the functions of switch cabinet online monitoring, temperature and humidity automatic monitoring, automatic control of an electric hand and a car grounding knife, arc light protection, protecting monitoring, five-protecting interlocking and vacuum degree online monitoring are integrally achieved, the intelligent and visible requirements of primary equipment can be met, safe operation of the primary equipment and safe operation of a power grid are effectively guaranteed, maintenance cost of the equipment is reduced, and the integrated switch cabinet intelligent operating system has significant meanings for the operation of the power grid and achievement of the lean management of the equipment.

This invention is in the area of dosage formulations and methods of administering a CDK4 / 6 inhibitor for the transient protection of healthy cells, and in particular hematopoietic stem and progenitor cells (HSPC), from damage associated with DNA damaging chemotherapeutic agents in subjects undergoing DNA damaging chemotherapeutic therapies for the treatment of proliferative disorders. In one aspect, improved protection of healthy cells is disclosed using a dosage that provides desirable pharmacokinetic and pharmacodynamic characteristics, including AUC, Tmax, Cmax, dosage-corrected AUC, and dosage-corrected Cmax. In another aspect, a method of treating a subject undergoing chemotherapy for the treatment of a CDK 4 / 6-replication independent cellular proliferation disorder by administering Compound 1 is provided.

The invention relates to a safety brake system. The safety brake system comprises a power source and at least one resistance mechanism. The resistance mechanism comprises a telescopic supporting mechanism and a friction assembly. Each telescopic supporting mechanism comprises a first telescopic cylinder hinged to and arranged on a connecting piece, wherein the lower end of a telescopic rod of the first telescopic cylinder is hinged to an installation plate of the friction assembly, a draw and pull rod is hinged to the upper surface of a friction plate, the upper end of the draw and pull rod is hinged to and arranged on the connecting piece, and a triangular structure is defined by the draw and pull rod, the telescopic rod of the first telescopic cylinder and the connecting piece on the upper portion. The invention further relates to a motor vehicle. The safety brake system is adopted for the motor vehicle and arranged on a chassis of the motor vehicle. Under the condition that brake failure happens to the motor vehicle or the vehicle is out of control or a vehicle-mounted brake system can not meet the requirement for braking, strong speed reduction braking can be rapidly achieved by starting the safety brake system, and therefore the brake distance can be shortened; in addition, the safety brake system has the advantages of being stable in traveling, safe, capable of preventing thievery, beneficial to motor vehicle overhauling, capable of protecting the chassis, and the like.

A system, according to an embodiment of the present invention, having an optical device and a shock attenuator is provided. The optical device is configured to operate with a weapon. The shock attenuator is disposed between the optical device and the weapon. The system includes the shock attenuator that is configured to reduce shock experienced by the optical device during operation of the weapon to less than 250 g's.

The present invention relates to a thermally releasable sheet-integrated film for semiconductor back surface, which includes: a pressure-sensitive adhesive sheet including a base material layer and a pressure-sensitive adhesive layer, and a film for semiconductor back surface formed on the pressure-sensitive adhesive layer of the pressure-sensitive adhesive sheet, in which the pressure-sensitive adhesive sheet is a thermally releasable pressure-sensitive adhesive sheet whose peel force from the film for semiconductor back surface decreases upon heating.

A method and apparatus for protecting shared data and method and apparatus for reproducing data from a recording medium using a local storage are disclosed. The present invention includes downloading the shared data associated with a recording medium to a local storage and permitting an application having valid access information for the shared data to access the shared data. The present invention includes downloading encrypted shared data associated with the recording medium to the local storage, constructing a virtual package including the shared data by binding data within the local storage to data within the recording medium, decrypting the shared data using the virtual package, and reproducing the decrypted shared data. Accordingly, the contents provided by an authentic content provider and the non-transmuted contents can be reproduced, whereby the shared data can be protected. And, the shared data can be protected against a malicious function caused by an unauthorized application.

The invention discloses a human ovocyte cryoprotectant. The human ovocyte cryoprotectant contains an ovum refrigerating fluid and an ovum thawing fluid, wherein the ovum refrigerating fluid contains a balance fluid and a refrigerating fluid; the ovum thawing fluid contains a resuscitation fluid, a diluent-1, a diluent-2 and a cleaning solution. The human ovocyte cryoprotectant is developed by combined application of the propanediol and glycol permeable cryoprotectants, and taking the trehalose (trehalose, alpha-D-glucopyranosyl alpha-D-glucopyranoside, C12H22O11) as a non-permeating agent. The non-permeating cryoprotectant suitable for freezing the human ovocyte is developed so that the formation of the ice crystal in the cell can be inhibited, the function of the frozen ovum can be protected and the developmental potentiality of the frozen ovocyte can be greatly improved. The clinical result proves that the fertility rate, the cleavage rate and the high quality blastocyst rate of the frozen ovocyte can be greatly improved.

The invention relates to a method for preparing bonito stick protein hydrolysate with an effect of reducing uric acid. The method comprises the following main steps of raw material heat treatment, restriction digestion, membrane separation-anion exchange chromatography-gel filtration chromatography separation, concentration and spray drying so as to obtain the bonito stick protein hydrolysate with an effect of reducing uric acid. The amino acid analysis indicates that the zymolyte peptide fragment primary amino acid sequence contains four amino acids, namely histidine, arginine, lysine and threonine, the total mass content of the four amino acids is 70 percent of the total amino acid content of zymolyte. MALDI-TOF-MS mass spectrum determines that the molecular weight of the main peptide effective ingredient is less than 700Da. In-vitro uric acid reduction experiments prove that the bonito stick protein hydrolysate has a remarkable effect of inhibiting generation of uric acid, and has an inhibition rate over 50 percent; an oteracil potassium molded hyperuricemic rat animal model indicates that the bonito stick protein hydrolysate can be used for remarkably reducing the level of serum uric acid and serum creatinine of rats, and shows a relatively good kidney protecting effect.

The invention relates to an anti-allergic composition for relieving as well as an application thereof. The anti-allergic composition for relieving comprises the following components: a first anti-allergic composition, a second anti-allergic composition, an anti-allergic peptide composition, Crambe abyssinica seed oil, bisabolol, and a Cardiospermum halicacabum extract product; the active componentof the first anti-allergic composition comprises 4-tert-butylcyclohexanol and 2-(3-(4-hydroxyphenyl)propanamido)benzoic acid; the active components of the second anti-allergic composition comprise anextract product of Stephania tetrandra, potassium lactate, phenoxyethanol, and dipotassium glycyrrhizinate; the active components of the anti-allergic composition comprise palmitoyl tripeptide-8 andacetyl tetrapeptide-15. The anti-allergic composition for relieving is evaluated by a macrophage nitric oxide inflammation releasing model, inhibition rate of nitric oxide releasing reaches 46.07%, and inhibition rate of histamine reaches 61.59%.

The invention relates to Bifidobacterium CECT 7765 and to the use thereof in the prevention and / or treatment of overweight, obesity and related pathologies. The invention likewise relates to the Bifidobacterium CECT7765 strain, to the cellular components, metabolites and secreted molecules thereof, to the combinations thereof with other microorganisms, and to compositions that include the preceding products, as well as to the use of one strain of the species Bifidobacterium pseudocatenulatumo and to the use of the CECT 7765 strain for preventing and / or treating obesity; excess weight; hyperglycemia; and diabetes, preferably type-2 Diabetes Mellitus; hepatic steatosis or fatty liver; dyslipidemia; metabolic syndrome; immune system dysfunction associated with obesity and excess weight; and an imbalance in the composition of the intestinal microbiota associated with obesity and excess weight.

The invention discloses a frozen stock solution of neural stem cells and an application method of the frozen stock solution. The frozen stock solution contains B-27 Supplement without retinoic acid, L-Glutamine, EGF, FGF and vitamin E in Neurobasal-A medium. The frozen stock solution is low in cost; the problem of low thawing rate after existing neural stem cells are frozen is critically solved; and the frozen thawing rate of the neural stem cells is improved.

Embodiments of the present invention include the in vivo and in vitro use of a family of anticancer heterocyclic compounds containing a quaternary ammonium group as exemplified by the thioxanthone and thioxanthene compounds [3-(3,4-dimethyl-9-oxo-9H-thioxanthen-2-yloxy)-2-hydroxypropyl]trimethylammonium chloride, or CCompound1, N,N,-diethyl-N-methyl-2-[9-oxo-9H-thioxanthen-2-yl)methoxy]ethanaminium iodide, or CCompound3, and N,N,N-trimethyl-3-(9H-thioxanthen-9-ylidene)-propane-1-aminium iodide, or CCompound19 to maintain and increase viability of normal endocrine and exocrine pancreatic cells under pathological conditions, such as type 1 and type 2 diabetes, pancreatitis, pancreatic cancer, or during and after islet transplant, or in preparation for transplant of isolated islet cells via (i) direct contact with these cells, and / or via (ii) enhancing survival and proliferation of endogenous or transplanted adult stem cells, and / or via (iii) reducing viability of pancreatic cancer cells.

A method, system and program product for managing energy diversion investigations. An energy diversion case is identified and case information is entered into an energy diversion investigation application. The data entered into the application is automatically accumulated and stored in an energy diversion investigations database. An energy diversion case file is generated and updated by an investigator assigned to the energy diversion case. The energy diversion case file can include case information, condition found, people involved in the energy diversion case, cost and recovery information, legal action taken and account information regarding the premises for which the investigation is being conducted. A revenue protection component determines a cost and a recovery amount associated with the energy diversion case. A report component generates predefined or custom reports for management and analysis.

The invention provides supermolecular hydrogel containing chitosan and gelatin as well as a preparation method and an application of the supermolecular hydrogel and belongs to the field of biomaterials. The supermolecular hydrogel contains a part formed by combining chitosan modified with a beta-cyclodextrin carboxylated derivative and gelatin under the host-guest interaction; chitosan is graftedwith the beta-cyclodextrin carboxylated derivative through an amide group. The preparation method comprises the steps as follows: the chitosan is grafted with the activated beta-cyclodextrin carboxylated derivative through the amide group, then, the gelatin is added, so that the grafted beta-cyclodextrin carboxylated derivative and an aromatic group of the gelatin are in host-guest interaction, and the supermolecular hydrogel containing the chitosan and the gelatin is obtained. The supermolecular hydrogel containing the chitosan and the gelatin has shear thinning and self-healing characteristics and can be used as an injectable cell or drug carrier. The beta-cyclodextrin group in hydrogel and the aromatic group in the gelatin can be used in cell carriers and tissue engineering materials through the host-guest interaction.

An ESD protection device includes a p-well with first protrudent portions, an N-well with second protrudent portions, a P-well / N-well boundary, a PMOS transistor disposed in the N-well, an NMOS transistor disposed in the P-well, first P+ diffusion regions in the first protrudent portions, first N+ diffusion regions in the second protrudent portions, second P+ diffusion regions disposed between the PMOS transistor and the second protrudent portions, second N+ diffusion regions disposed between the NMOS transistor and the first protrudent portions, third P+ diffusion regions disposed between the NMOS transistor, the boundary, and two adjacent second P+ diffusion regions, and third N+ diffusion regions disposed between the PMOS transistor, the boundary, and two adjacent second N+ diffusion regions, wherein the first and second protrudent portions are interlacedly arranged at the boundary.

The invention relates to a high-performance high-density polyethylene (HDPE) pipe fitting which consists of functional master batches and an HDPE base material. A preparation method is characterized by comprising the following steps of: selecting raw materials, mixing the raw materials, feeding the raw materials under vacuum, drying the raw materials, extruding the raw materials by an inner layer extruder, extruding the raw materials by an outer layer extruder, fixing the diameter by a diameter fixing sleeve, spraying a vacuum sizing box, spraying a cooling water tank, spraying codes by a code sprayer, conveying a product by a caterpillar-tractor, packaging finished products, and detecting the specifications of the HDPE pipe fittings. The HDPE pipe fitting can be produced by using existing equipment and a production technology; the additional value of the products can be increased; the HDPE pipe fitting can be widely applied.

The invention relates to a precision forging process production line for a steel rail turnout, which is characterized in that the precision forging process production line comprises a steel rail turnout precision forging press, a heating furnace, a normalizing furnace, a steel rail forward conveying device, an automatic steel rail feeding mechanism and an automatic steel rail blanking mechanism; a steel rail transversely-conveying trolley is arranged between the automatic steel rail feeding mechanism and the automatic steel rail blanking mechanism; a transversal motion guide rail and a transmission gear rack are arranged under the steel rail transversely-conveying trolley; a plurality of steel rail precision feeding devices and a servomotor are arranged on the steel rail transversely-conveying trolley; and an electric cabinet used for controlling the operation of the whole production line is arranged on the outer side of the automatic steel rail feeding mechanism. The precision forging process production line has the advantages as follows: the production line is suitable for hot compression molding technology of various AT (abbreviation for Pinyin of 'short-type cross section') steel rail turnouts, and all devices and mechanisms of the production line can achieve automation control without manual intervention, so that time and labor are saved, the labor intensity of operators is reduced, the processing period of the steel rail turnout is shortened, the production cost is lowered, the machining precision and the qualification rate of the steel rail are improved, and the requirement of high-quality steel rail can be satisfied further.

This application relates to new formulations of vitamin K1 and K2 provitamins. These formulations can be used as nutraceuticals, e.g. for the fortification of foods or simply in supplements or can be used in pharmaceuticals for the treatment of a variety of conditions known to benefit from the administration of vitamin K1 and K2.

The invention provides a method for regulating and controlling calcium ion concentration of vitrification frozen bovine oocytes. The method comprises the following steps: placing bovine oocytes being mature in vitro for 22 hours in in-vitro mature liquid containing BAPTA-AM for incubating for 2 hours; then, freezing with a vitrification freezing solution containing 10muM BAPTA-AM and 1muM RR by adopting an OPS technology; unfreezing, and recovering for 30 minutes in in-vitro mature liquid containing RR in order to remarkably improve the cleavage rate, blastocyst rate, blastocyst cell number, in-vitro fertility and developmental capacity of the vitrification frozen bovine oocytes. The method is easy to operate, is low in cost, is nontoxic and harmless to the oocytes, can be used for effectively protecting the mitochondrial function and the developmental capacity of the vitrification frozen bovine oocytes, has important theoretical and practical significance to the expansion of the application range of the frozen bovine oocytes, and plays an important role in the field of ultralow-temperature freezing research of the bovine oocytes.

The invention relates to a solar battery backplane composite film and the manufacturing method. The solar battery backplane composite film consists of the following three materials: poly fluoride film with a thickness of 0.035mm to 0.045mm; PET film with a thickness of 0.18mm to 0.30mm; poly fluoride film with a thickness of 0.035mm to 0.045mm. The manufacturing method comprises the following steps: the surfaces of the poly fluoride film and the PET film are covered by a firming agent; the PET film is positioned between the two poly fluoride films; and the solar battery backplane composite film is obtained by heat pressing and adhesion and solidifying. The manufacturing technique of the solar battery backplane composite film of the invention is simple and has a good property. The solar battery panel encapsulated after the products prevents effectively the erosion of vapor, oxygen and corrosive gas-liquid, and has the advantages of high and low temperature resistance, anti-aging, and anti-cracking, thus effectively protecting the battery functions and making the solar battery panel output electricity energy for a long time.

The invention relates to a method and a device, by which eggs in shells are subjected to heat treatment using a liquid or gaseous or vaporous medium, wherein pasteurization is carried out at a temperature in a range from 70 to 75° C. The object of the invention is to destroy or temporarily render dormant harmful microorganisms that can be destroyed at low heat, and further harmful microorganisms and viruses that cannot be destroyed at low heat, wherein altering of the eggs and / or denaturation of the proteins thereof should be prevented. It is proposed to subject the eggs, prior to pasteurization, to a preheating step at a temperature of substantially 60° C., followed by shock-like cooling to 4° to 5° C., and to carry out pasteurization for a duration of between 12 to 18 seconds.

The invention relates to the technical field of dairy products, in particular to formula goat milk powder for pregnant women and a preparation method of the formula goat milk powder. The formula goat milk powder for pregnant women comprises the following ingredients in parts by weight: 500 to 600 parts of fresh goat milk, 30 to 40 parts of demineralized whey powder, 5 to 10 parts of whey protein powder, 2 to 6 parts of walnut oil, 2 to 6 parts of fructo-oligose, 0.6 to 1 part of docosahexaenoic acid (DHA), 0.1 to 0.2 parts of choline, 450 to 600 parts of folic acid, 0.2 to 0.5 parts of complex vitamins and 0.2 to 0.6 parts of complex trace elements, and the formula goat milk powder is prepared according to a certain method. The DHA, the walnut oil and the fructo-oligose are added according to the nutrition requirements of the pregnant and lying-in women and the growth and development requirements of babies, and the nutrition elements including folic acid, calcium, ferrum, zinc and the like are enhanced, so the self DHA and the choline of the pregnant women are improved, the concentration in the body is maintained at a high-level state, and the excellent and sufficient nutrition can be provided in the fast development period of the brain of the babies.

The invention provides a preparation method of a selenium-rich humic acid water soluble fertilizer. The method is characterized by comprising the following steps: 1) preparing organic selenium; 2) acidizing humic acid; 3) stirring; 4) chelating; 5) concentrating. The method provided by the invention is simple to operate and easy to implement. According to the method, the prepared water soluble fertilizer can be used for lowering the residual quantity of heavy metals and pesticides in agricultural products so as to guarantee the quality safety of the agricultural products, and can improve the yield of crops at the same time, thereby conforming to the standard of selenium-rich agricultural products in China. As a result, the prepared water soluble fertilizer has a wide market prospect.

The invention relates to a focusing ultrasonic cavitation treatment instrument which is used for treating tumor, thrombolysis, ischemic myocardium and disease of prostate based on the cavitation effect of the ultrasonic contrast agent microvesicle. The focusing ultrasonic cavitation treatment instrument comprises a main control machine, two combined treatment probes, and a B ultrasonic machine with an ultrasonic focusing ultrasonic cavitation treatment instrument function. The focusing ultrasonic cavitation treatment instrument is mainly used for the partial area of the focus, and carries out non-invasive treatment on the tumor based on the cavitation effect of the microvesicle. The microvesicle can greatly improve the cavitation effect, so that the ultrasonic focusing positioning radiation with low power can be precisely carried out in the partial area of the focus, and the cavitation effect of the microvesicle within the vessel just can be activated within the partial area, and the capillaries in the tumor can be subject to embolism and damage, so as to achieve the purpose of 'starving' the tumor. The threshold for generating the cavitation is not met by the ultrasonic energy at the periphery of the focusing area, so that the cavitation effect is not generated, so that the path where the ultrasonic wave passes or the ambient tissue can not be damaged; and the functions of the common tissue and organs are protected.